Terms: = Brain cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
245 results:
1. Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types.
Kim DK; Lee CY; Han YJ; Park SY; Han H; Na K; Kim MH; Yang SM; Baek S; Kim Y; Hwang JY; Lee S; Kang SS; Hong MH; Lim SM; Lee JB; Kim JH; Cho BC; Pyo KH
Front Immunol; 2024; 15():1330228. PubMed ID: 38680496
[TBL] [Abstract] [Full Text] [Related]
2. Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study.
Nguyen AV; Soto JM; Digbeu BD; Nguyen CY; Wu E; Huang JH; Kuo YF
Neurol Res; 2024 May; 46(5):379-390. PubMed ID: 38415699
[TBL] [Abstract] [Full Text] [Related]
3. Stereotactic radiosurgery of brain metastases: a retrospective study.
Gruber I; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of indoleamine 2, 3-dioxygenase-1 expression in glial tumors.
Kaya M; Aksoy A; Artas G; Kaplan M
Ideggyogy Sz; 2023 Sep; 76(9-10):339-347. PubMed ID: 37782060
[TBL] [Abstract] [Full Text] [Related]
5. Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian cancer.
Leman R; Muller E; Legros A; Goardon N; Chentli I; Atkinson A; Tranchant A; Castera L; Krieger S; Ricou A; Boulouard F; Joly F; Boucly R; Dumont A; Basset N; Coulet F; Chevalier LM; Rouleau E; Leitner K; González-Martin A; Gargiulo P; Lück HJ; Genestie C; ; Ray-Coquard I; Pujade-Lauraine E; Vaur D
Clin Cancer Res; 2023 Nov; 29(21):4419-4429. PubMed ID: 37756555
[TBL] [Abstract] [Full Text] [Related]
6. Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta-analysis of real-world survival outcomes of East Asian patients with advanced non-small cell lung cancer treated with first-line EGFR-TKIs.
Chang HC; Wang CC; Tseng CC; Huang KT; Chen YM; Chang YP; Lai CH; Fang WF; Lin MC; Chuang HY
Thorac Cancer; 2023 Nov; 14(32):3208-3216. PubMed ID: 37737541
[TBL] [Abstract] [Full Text] [Related]
7. The relationship of lifetime history of depression on the ovarian tumor immune microenvironment.
Hathaway CA; Townsend MK; Conejo-Garcia JR; Fridley BL; Moran Segura C; Nguyen JV; Armaiz-Pena GN; Sasamoto N; Saeed-Vafa D; Terry KL; Kubzansky LD; Tworoger SS
Brain Behav Immun; 2023 Nov; 114():52-60. PubMed ID: 37557966
[TBL] [Abstract] [Full Text] [Related]
8. Association Between Pseudoprogression of Vestibular Schwannoma After Radiosurgery and Radiological Features of Solid and Cystic Components.
Huang CY; Peng SJ; Yang HC; Wu HM; Chen CJ; Wang MC; Hu YS; Lin CJ; Shiau CY; Guo WY; Chung WY; Pan DH; Lee CC
Neurosurgery; 2023 Dec; 93(6):1383-1392. PubMed ID: 37432016
[TBL] [Abstract] [Full Text] [Related]
9. Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study.
Liu ZD; Wang SQ; Li S; He J; Wang SH; Cai HQ; Wan JH
Clinics (Sao Paulo); 2023; 78():100212. PubMed ID: 37201304
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex.
Klonowska K; Giannikou K; Grevelink JM; Boeszoermenyi B; Thorner AR; Herbert ZT; Afrin A; Treichel AM; Hamieh L; Kotulska K; Jozwiak S; Moss J; Darling TN; Kwiatkowski DJ
Am J Hum Genet; 2023 Jun; 110(6):979-988. PubMed ID: 37141891
[TBL] [Abstract] [Full Text] [Related]
11. Health litigation and cancer survival in patients treated in the public health system in a large Brazilian city, 2014-2019.
de Castro MSM; da Silva GDM; Figueiredo IVO; de Miranda WD; Magalhães Júnior HM; Dos Santos FP; de Sousa RP
BMC Public Health; 2023 Mar; 23(1):534. PubMed ID: 36944943
[TBL] [Abstract] [Full Text] [Related]
12. Exploring the relationships between hormone receptor, HER2 status, and bone involvement in the first distant metastases of in Chinese breast cancer patients who lacked HER2 targeted therapy.
Jia Z; Dai M; Shang Y; Li Y; Li Z
BMC Cancer; 2023 Jan; 23(1):93. PubMed ID: 36703144
[TBL] [Abstract] [Full Text] [Related]
13. Defining the Phenotype and Prognosis of People With Idiopathic Intracranial Hypertension After Cerebrospinal Fluid Diversion Surgery.
Hyder YF; Homer V; Thaller M; Byrne M; Tsermoulas G; Piccus R; Mollan SP; Sinclair AJ
Am J Ophthalmol; 2023 Jun; 250():70-81. PubMed ID: 36682516
[TBL] [Abstract] [Full Text] [Related]
14. Compassionate use of recombinant human IL-7-hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma.
Ahn S; Park JS; Kim H; Heo M; Sung YC; Jeun SS
Cancer Med; 2023 Mar; 12(6):6778-6787. PubMed ID: 36583472
[TBL] [Abstract] [Full Text] [Related]
15. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract] [Full Text] [Related]
16. Male origin microchimerism and brain cancer: a case-cohort study.
Kamper-Jørgensen M; Jakobsen MA; Tjønneland A; Skjøth-Rasmussen J; Petersen GL; Hallum S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5469-5474. PubMed ID: 36462037
[TBL] [Abstract] [Full Text] [Related]
17.
Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J
Front Immunol; 2022; 13():974346. PubMed ID: 36275718
[TBL] [Abstract] [Full Text] [Related]
18. Predictive Model to Guide brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung cancer: Impact on Real-World Outcomes.
Wu J; Ding V; Luo S; Choi E; Hellyer J; Myall N; Henry S; Wood D; Stehr H; Ji H; Nagpal S; Hayden Gephart M; Wakelee H; Neal J; Han SS
JCO Precis Oncol; 2022 Oct; 6():e2200220. PubMed ID: 36201713
[TBL] [Abstract] [Full Text] [Related]
19. Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial.
Gu W; Han W; Luo H; Zhou F; He D; Ma L; Guo H; Liang C; Chong T; Jiang J; Chen Z; Wang Y; Zou Q; Tian Y; Xiao J; Huang J; Zhu S; Dong Q; Zhang X; Li H; Yang X; Chen C; Li J; Jin C; Zhang X; Ye D;
Lancet Oncol; 2022 Oct; 23(10):1249-1260. PubMed ID: 36075260
[TBL] [Abstract] [Full Text] [Related]
20. Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.
Chu WY; Allegaert K; Dorlo TPC; Huitema ADR;
Clin Pharmacokinet; 2022 Nov; 61(11):1545-1558. PubMed ID: 36040612
[TBL] [Abstract] [Full Text] [Related]
[Next]
